Ultragenyx Pharmaceutical shares owned by BlackRock
Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Ultragenyx Pharmaceutical
Tip: Access up to 7 years of quarterly data
All positions including Ultragenyx Pharmaceutical held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Ultragenyx Pharmaceutical by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $230M | 5.6M | 41.10 |
| 2024-03-31 | $245M | 5.2M | 46.69 |
| 2023-09-30 | $181M | 5.1M | 35.65 |
| 2023-06-30 | $234M | 5.1M | 46.13 |
| 2023-03-31 | $195M | 4.9M | 40.10 |
| 2022-12-31 | $201M | 4.3M | 46.33 |
| 2022-06-30 | $215M | 3.6M | 59.67 |
| 2021-06-30 | $333M | 3.5M | 95.35 |
| 2021-03-31 | $622M | 5.5M | 113.85 |
| 2020-12-31 | $732M | 5.3M | 138.42 |
| 2020-09-30 | $395M | 4.8M | 82.18 |
| 2020-03-31 | $203M | 4.6M | 44.44 |
| 2019-12-31 | $202M | 4.7M | 42.70 |
| 2019-09-30 | $198M | 4.6M | 42.79 |
| 2019-06-30 | $281M | 4.4M | 63.51 |
| 2019-03-31 | $329M | 4.7M | 69.37 |
| 2018-12-31 | $195M | 4.5M | 43.48 |
| 2018-09-30 | $332M | 4.4M | 76.34 |
| 2018-06-30 | $337M | 4.4M | 76.87 |
| 2018-03-31 | $216M | 4.2M | 51.00 |
| 2017-09-30 | $200M | 3.8M | 53.27 |
| 2016-12-31 | $217k | 3.1k | 70.21 |
| 2016-09-30 | $301k | 4.2k | 70.94 |
| 2016-06-30 | $195k | 4.0k | 49.01 |
| 2016-03-31 | $159k | 2.5k | 63.41 |
| 2015-12-31 | $4.2M | 37k | 112.19 |
| 2015-09-30 | $4.1M | 42k | 96.30 |
| 2015-06-30 | $95k | 907 | 104.84 |
| 2015-03-31 | $10k | 167 | 59.88 |
| 2014-12-31 | $7.0k | 167 | 41.92 |
| 2014-09-30 | $9.0k | 167 | 53.89 |
| 2014-06-30 | $7.0k | 167 | 41.92 |
| 2014-03-31 | $531k | 11k | 48.88 |